Current Limitations and Candidate Potential of 5-HT7 Receptor Antagonism in Psychiatric Pharmacotherapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current Limitations and Candidate Potential of 5-HT7 Receptor Antagonism in Psychiatric Pharmacotherapy
Authors
Keywords
-
Journal
Frontiers in Psychiatry
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-02-21
DOI
10.3389/fpsyt.2021.623684
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of Subchronic Administrations of Vortioxetine, Lurasidone, and Escitalopram on Thalamocortical Glutamatergic Transmission Associated with Serotonin 5-HT7 Receptor
- (2021) Motohiro Okada et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pathogenesis and pathophysiology of autosomal dominant sleep‐related hypermotor epilepsy with S284L‐mutant α4 subunit of nicotinic ACh receptor
- (2020) Kouji Fukuyama et al. BRITISH JOURNAL OF PHARMACOLOGY
- Evaluating lurasidone as a treatment option for bipolar disorder
- (2020) Ziad Ali et al. EXPERT OPINION ON PHARMACOTHERAPY
- Role of the Serotonin Receptor 7 in Brain Plasticity: From Development to Disease
- (2020) Marianna Crispino et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effects of NBI-98782, a selective vesicular monoamine transporter 2 (VMAT2) inhibitor, on neurotransmitter efflux and phencyclidine-induced locomotor activity: Relevance to tardive dyskinesia and antipsychotic action
- (2020) Mei Huang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Augmenting Computerized Cognitive Training With Vortioxetine for Age-Related Cognitive Decline: A Randomized Controlled Trial
- (2020) Eric J. Lenze et al. AMERICAN JOURNAL OF PSYCHIATRY
- High Frequency of Undiagnosed Psychiatric Disorders in Inflammatory Bowel Diseases
- (2020) Irene Marafini et al. Journal of Clinical Medicine
- Cost of Relapse Management in Patients with Schizophrenia in Italy and Spain: Comparison Between Lurasidone and Quetiapine XR
- (2020) Umberto Restelli et al. CLINICAL DRUG INVESTIGATION
- Interaction between Mesocortical and Mesothalamic Catecholaminergic Transmissions Associated with NMDA Receptor in the Locus Coeruleus
- (2020) Motohiro Okada et al. Biomolecules
- Upregulated and Hyperactivated Thalamic Connexin 43 Plays Important Roles in Pathomechanisms of Cognitive Impairment and Seizure of Autosomal Dominant Sleep-Related Hypermotor Epilepsy with S284L-Mutant α4 Subunit of Nicotinic ACh Receptor
- (2020) Kouji Fukuyama et al. Pharmaceuticals
- A Working Hypothesis Regarding Identical Pathomechanisms between Clinical Efficacy and Adverse Reaction of Clozapine via the Activation of Connexin43
- (2020) Motohiro Okada et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effects of acute and sub-chronic administrations of guanfacine on catecholaminergic transmissions in the orbitofrontal cortex
- (2019) Motohiro Okada et al. NEUROPHARMACOLOGY
- Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
- (2019) Michael Platten et al. NATURE REVIEWS DRUG DISCOVERY
- A functional variant in the serotonin receptor 7 gene (HTR7), rs7905446, is associated with good response to SSRIs in bipolar and unipolar depression
- (2019) Ya Bin Wei et al. MOLECULAR PSYCHIATRY
- Lurasidone inhibits NMDA/glutamate antagonist‐induced functional abnormality of thalamocortical glutamatergic transmission via 5‐HT 7 receptor blockade
- (2019) Motohiro Okada et al. BRITISH JOURNAL OF PHARMACOLOGY
- Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone
- (2019) Filippo Corponi et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Intravenous vortioxetine to accelerate onset of effect in major depressive disorder
- (2019) Eduard Vieta et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
- (2019) Maximilian Huhn et al. LANCET
- Clozapine Normalizes a Glutamatergic Transmission Abnormality Induced by an Impaired NMDA Receptor in the Thalamocortical Pathway via the Activation of a Group III Metabotropic Glutamate Receptor
- (2019) Fukuyama et al. Biomolecules
- Thalamocortical Circuit Motifs: A General Framework
- (2019) Michael M. Halassa et al. NEURON
- The blockade of the serotoninergic receptors 5-HT5A, 5-HT6 and 5-HT7 in the basolateral amygdala, but not in the hippocampus facilitate the extinction of fear memory
- (2019) Eduardo Silva de Assis Brasil et al. BEHAVIOURAL BRAIN RESEARCH
- Towards selective CNS PET imaging of the 5-HT7 receptor system: Past, present and future
- (2019) Elina T. L'Estrade et al. NEUROPHARMACOLOGY
- A functional HTR1A polymorphism, rs6295, predicts short-term response to lurasidone: confirmation with meta-analysis of other antipsychotic drugs
- (2019) Akane Yoshikawa et al. PHARMACOGENOMICS JOURNAL
- Pharmacological Discrimination of Effects of MK801 on Thalamocortical, Mesothalamic, and Mesocortical Transmissions
- (2019) Okada et al. Biomolecules
- Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia
- (2019) Stefan Leucht et al. AMERICAN JOURNAL OF PSYCHIATRY
- Vortioxetine Subchronically Activates Serotonergic Transmission via Desensitization of Serotonin 5-HT1A Receptor with 5-HT3 Receptor Inhibition in Rats
- (2019) Motohiro Okada et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pharmacology and Therapeutic Potential of the 5-HT7 receptor
- (2018) Kevin M Blattner et al. ACS Chemical Neuroscience
- Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines
- (2018) N. Verdolini et al. ACTA PSYCHIATRICA SCANDINAVICA
- The Mediodorsal Thalamus: An Essential Partner of the Prefrontal Cortex for Cognition
- (2018) Sébastien Parnaudeau et al. BIOLOGICAL PSYCHIATRY
- New Trends in the Treatment of Schizophrenia
- (2018) Herbert Y. Meltzer CNS & Neurological Disorders-Drug Targets
- Targeting the cellular schizophrenia. Likely employment of the antipsychotic agent pimozide in treatment of refractory cancers and glioblastoma
- (2018) Ilhan Elmaci et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Input Convergence, Synaptic Plasticity and Functional Coupling Across Hippocampal-Prefrontal-Thalamic Circuits
- (2018) Lezio S. Bueno-Junior et al. Frontiers in Neural Circuits
- Effects of levetiracetam on astroglial release of kynurenine-pathway metabolites
- (2018) Kouji Fukuyama et al. BRITISH JOURNAL OF PHARMACOLOGY
- Serotonin receptors in depression and anxiety: Insights from animal studies
- (2018) Elżbieta Żmudzka et al. LIFE SCIENCES
- Psychosis in neurodegenerative disorders
- (2018) Wael K. Karameh et al. CURRENT OPINION IN PSYCHIATRY
- Cystine/Glutamate Antiporter and Aripiprazole Compensate NMDA Antagonist-Induced Dysfunction of Thalamocortical L-Glutamatergic Transmission
- (2018) Kouji Fukuyama et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Activation of Serotonin 5-HT7 Receptors Modulates Hippocampal Synaptic Plasticity by Stimulation of Adenylate Cyclases and Rescues Learning and Behavior in a Mouse Model of Fragile X Syndrome
- (2018) Lara Costa et al. Frontiers in Molecular Neuroscience
- Pharmacological Treatment of Major Depressive Episodes with Mixed Features: A Systematic Review
- (2018) In Hee Shim et al. Clinical Psychopharmacology and Neuroscience
- Liver 5-HT7 receptors: A novel regulator target of fibrosis and inflammation-induced chronic liver injury in vivo and in vitro
- (2017) Beyzagul Polat et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Replication of rs300774, a genetic biomarker near ACP1, associated with suicide attempts in patients with schizophrenia: Relation to brain cholesterol biosynthesis
- (2017) Jiang Li et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Efficacy and Safety of Lurasidone in Children and Adolescents With Bipolar I Depression: A Double-Blind, Placebo-Controlled Study
- (2017) Melissa P. DelBello et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Osteopontin inhibits osteoblast responsiveness through the down-regulation of focal adhesion kinase mediated by the induction of low–molecular weight protein tyrosine phosphatase
- (2017) Joji Kusuyama et al. MOLECULAR BIOLOGY OF THE CELL
- Modulation of the consolidation and reconsolidation of fear memory by three different serotonin receptors in hippocampus
- (2017) S.D. Schmidt et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- CaMKII Autophosphorylation Is Necessary for Optimal Integration of Ca 2+ Signals during LTP Induction, but Not Maintenance
- (2017) Jui-Yun Chang et al. NEURON
- Toward a theoretical role for tonic norepinephrine in the orbitofrontal cortex in facilitating flexible learning
- (2017) Brian F. Sadacca et al. NEUROSCIENCE
- Neurochemical arguments for the use of dopamine D 4 receptor stimulation to improve cognitive impairment associated with schizophrenia
- (2017) Mei Huang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Lurasidone in post-menopausal females with major depressive disorder with mixed features: Post-hoc analysis of a placebo-controlled trial
- (2017) John Sramek et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- How serotonin receptors regulate morphogenic signalling in neurons
- (2017) Alexander Wirth et al. PROGRESS IN NEUROBIOLOGY
- Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis
- (2017) Michael Ostacher et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Synaptic Remodeling Depends on Signaling between Serotonin Receptors and the Extracellular Matrix
- (2017) Monika Bijata et al. Cell Reports
- Placebo Response and Practice Effects in Schizophrenia Cognition Trials
- (2017) Richard S. E. Keefe et al. JAMA Psychiatry
- Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features: A Randomized, Double-Blind, Placebo-Controlled Study
- (2016) Trisha Suppes et al. AMERICAN JOURNAL OF PSYCHIATRY
- Hippocampal 5-HT7receptors signal phosphorylation of the GluA1 subunit to facilitate AMPA receptor mediated-neurotransmissionin vitroandin vivo
- (2016) Filippo Andreetta et al. BRITISH JOURNAL OF PHARMACOLOGY
- The sleep effects of lurasidone: a placebo-controlled cross-over study using a 4-h phase-advance model of transient insomnia
- (2016) Andrew D. Krystal et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Efficacy of Lurasidone in Adults Aged 55 Years and Older With Bipolar Depression
- (2016) Martha Sajatovic et al. JOURNAL OF CLINICAL PSYCHIATRY
- Effects of 5-HT-7 receptor ligands on memory and cognition
- (2016) Nicholas Zareifopoulos et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- The 5-HT7 receptor triggers cerebellar long-term synaptic depression via PKC-MAPK
- (2016) Pellegrino Lippiello et al. NEUROPHARMACOLOGY
- Morphological Alterations in the Thalamus, Striatum and Pallidum in Autism Spectrum Disorder
- (2016) Manuela Schuetze et al. NEUROPSYCHOPHARMACOLOGY
- Interventions for tic disorders: An overview of systematic reviews and meta analyses
- (2016) Chunsong Yang et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Socio-demographic and clinical predictors of non-response/non-remission in treatment resistant depressed patients: A systematic review
- (2016) Vera De Carlo et al. PSYCHIATRY RESEARCH
- Improvement of ketamine-induced social withdrawal in rats
- (2015) Małgorzata Hołuj et al. BEHAVIOURAL PHARMACOLOGY
- The atypical antipsychotics clozapine and olanzapine promote down-regulation and display functional selectivity at human 5-HT7receptors
- (2015) K W Andressen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cessation of gamma activity in the dorsomedial nucleus associated with loss of consciousness during focal seizures
- (2015) B.A. Leeman-Markowski et al. EPILEPSY & BEHAVIOR
- HTR1A Polymorphisms and Clinical Efficacy of Antipsychotic Drug Treatment in Schizophrenia: A Meta-Analysis
- (2015) Yoshiteru Takekita et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Lurasidone in the Treatment of Bipolar Depression With Mixed (Subsyndromal Hypomanic) Features
- (2015) Roger S. McIntyre et al. JOURNAL OF CLINICAL PSYCHIATRY
- Spinal 5-HT7 receptors induce phrenic motor facilitation via EPAC-mTORC1 signaling
- (2015) D. P. Fields et al. JOURNAL OF NEUROPHYSIOLOGY
- A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia
- (2015) Rajiv Tandon et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Serotonin 7 Receptor Variants Are Not Associated with Response to Second-Generation Antipsychotics in Japanese Schizophrenia Patients
- (2015) Yoshiteru Takekita et al. NEUROPSYCHOBIOLOGY
- Limbic circuitry of the midline thalamus
- (2015) Robert P. Vertes et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Serotonin (5-HT)1A receptor agonism and 5-HT7 receptor antagonism ameliorate the subchronic phencyclidine-induced deficit in executive functioning in mice
- (2015) Lakshmi Rajagopal et al. PSYCHOPHARMACOLOGY
- Effect of lurasidone dose on cognition in patients with schizophrenia: Post-hoc analysis of a long-term, double-blind continuation study
- (2015) Philip D. Harvey et al. SCHIZOPHRENIA RESEARCH
- Stimulation of 5-HT7 receptor during adolescence determines its persistent upregulation in adult rat forebrain areas
- (2015) Paola Nativio et al. SYNAPSE
- 5-HT7 receptor modulates GABAergic transmission in the rat dorsal raphe nucleus and controls cortical release of serotonin
- (2015) Magdalena Kusek et al. Frontiers in Cellular Neuroscience
- Activation of 5-HT7 receptor stimulates neurite elongation through mTOR, Cdc42 and actin filaments dynamics
- (2015) Luisa Speranza et al. Frontiers in Behavioral Neuroscience
- Spatial memory deficit across aging: current insights of the role of 5-HT7 receptors
- (2015) Gregory Beaudet et al. Frontiers in Behavioral Neuroscience
- Cost-effectiveness of lurasidone vs quetiapine extended-release (XR) in patients with bipolar depression
- (2015) Krithika Rajagopalan et al. JOURNAL OF MEDICAL ECONOMICS
- Neuronal Plasticity: Beyond the Critical Period
- (2014) Mark Hübener et al. CELL
- A stereological study of the mediodorsal thalamic nucleus in Down syndrome
- (2014) A.S. Karlsen et al. NEUROSCIENCE
- What Did STAR*D Teach Us? Results From a Large-Scale, Practical, Clinical Trial for Patients With Depression
- (2014) Bradley N. Gaynes et al. PSYCHIATRIC SERVICES
- The serotonin receptor 7 and the structural plasticity of brain circuits
- (2014) Floriana Volpicelli et al. Frontiers in Behavioral Neuroscience
- Lurasidone as Adjunctive Therapy With Lithium or Valproate for the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study
- (2013) Antony Loebel et al. AMERICAN JOURNAL OF PSYCHIATRY
- Lurasidone Monotherapy in the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study
- (2013) Antony Loebel et al. AMERICAN JOURNAL OF PSYCHIATRY
- Structural plasticity of dendritic spines: The underlying mechanisms and its dysregulation in brain disorders
- (2013) Kwok-On Lai et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- D2 receptor occupancy following lurasidone treatment in patients with schizophrenia or schizoaffective disorder
- (2013) Steven G. Potkin et al. CNS SPECTRUMS
- Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study
- (2013) Leslie Citrome et al. CNS SPECTRUMS
- Effect of lurasidone on neurocognitive performance in patients with schizophrenia: A short-term placebo- and active-controlled study followed by a 6-month double-blind extension
- (2013) Philip D. Harvey et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Translating the N-methyl-d-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia
- (2013) Herbert Y. Meltzer et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Effectiveness of Lurasidone for Patients With Schizophrenia Following 6 Weeks of Acute Treatment With Lurasidone, Olanzapine, or Placebo
- (2013) Stephen M. Stahl et al. JOURNAL OF CLINICAL PSYCHIATRY
- Targeted Inhibition of Serotonin Type 7 (5-HT7) Receptor Function Modulates Immune Responses and Reduces the Severity of Intestinal Inflammation
- (2013) J. J. Kim et al. JOURNAL OF IMMUNOLOGY
- Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT)2Aand DA D2antagonism and 5-HT1Apartial agonism
- (2013) Mei Huang et al. JOURNAL OF NEUROCHEMISTRY
- Brain RegionSpecific Transcriptomic Markers of Serotonin1A Receptor Agonist Action Mediating Sexual Rejection and Aggression in Female Marmoset Monkeys
- (2013) Yves Aubert et al. Journal of Sexual Medicine
- Zonisamide regulates basal ganglia transmission via astroglial kynurenine pathway
- (2013) Kouji Fukuyama et al. NEUROPHARMACOLOGY
- Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats
- (2013) Arne Mørk et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Determination of dopamine D2 receptor occupancy by lurasidone using positron emission tomography in healthy male subjects
- (2013) Dean F. Wong et al. PSYCHOPHARMACOLOGY
- Effectiveness of lurasidone vs. quetiapine XR for relapse prevention in schizophrenia: A 12-month, double-blind, noninferiority study
- (2013) Antony Loebel et al. SCHIZOPHRENIA RESEARCH
- Loss of TAK1 increases cell traction force in a ROS-dependent manner to drive epithelial–mesenchymal transition of cancer cells
- (2013) C R I Lam et al. Cell Death & Disease
- Profile of blonanserin for the treatment of schizophrenia
- (2013) Tomomi Tenjin et al. Neuropsychiatric Disease and Treatment
- Acute 5-HT7 receptor activation increases NMDA-evoked currents and differentially alters NMDA receptor subunit phosphorylation and trafficking in hippocampal neurons
- (2013) Maryam S Vasefi et al. Molecular Brain
- The serotonin 5-HT7 receptors: two decades of research
- (2013) Evelien Gellynck et al. EXPERIMENTAL BRAIN RESEARCH
- Annual cost of relapses and relapse-related hospitalizations in adults with schizophrenia: results from a 12-month, double-blind, comparative study of lurasidone vs quetiapine extended-release
- (2013) Krithika Rajagopalan et al. JOURNAL OF MEDICAL ECONOMICS
- Active Metabolites as Antidepressant Drugs: The Role of Norquetiapine in the Mechanism of Action of Quetiapine in the Treatment of Mood Disorders
- (2013) Francisco López-Muñoz et al. Frontiers in Psychiatry
- Activation of 5-HT7 Serotonin Receptors Reverses Metabotropic Glutamate Receptor-Mediated Synaptic Plasticity in Wild-Type and Fmr1 Knockout Mice, a Model of Fragile X Syndrome
- (2012) Lara Costa et al. BIOLOGICAL PSYCHIATRY
- Clozapine, but not haloperidol, enhances glial d-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes
- (2012) Shunske Tanahashi et al. BRITISH JOURNAL OF PHARMACOLOGY
- ONO-2506 inhibits spike-wave discharges in a genetic animal model without affecting traditional convulsive tests via gliotransmission regulation
- (2012) Satoshi Yamamura et al. BRITISH JOURNAL OF PHARMACOLOGY
- Long-term safety and tolerability of lurasidone in schizophrenia
- (2012) Leslie Citrome et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Heterodimerization of serotonin receptors 5-HT1A and 5-HT7 differentially regulates receptor signalling and trafficking
- (2012) U. Renner et al. JOURNAL OF CELL SCIENCE
- 5-HT7R/G12 Signaling Regulates Neuronal Morphology and Function in an Age-Dependent Manner
- (2012) F. Kobe et al. JOURNAL OF NEUROSCIENCE
- Electrophysiological and pharmacological properties of GABAergic cells in the dorsal raphe nucleus
- (2012) Yoshihiro Gocho et al. Journal of Physiological Sciences
- 5-HT1A and 5-HT7 receptor crosstalk in the regulation of emotional memory: Implications for effects of selective serotonin reuptake inhibitors
- (2012) Therese M. Eriksson et al. NEUROPHARMACOLOGY
- The serotonin receptor 7 promotes neurite outgrowth via ERK and Cdk5 signaling pathways
- (2012) L. Speranza et al. NEUROPHARMACOLOGY
- Evaluation of dopamine D2/D3 and serotonin 5-HT2A receptor occupancy for a novel antipsychotic, lurasidone, in conscious common marmosets using small-animal positron emission tomography
- (2012) Shunsuke Nakazawa et al. PSYCHOPHARMACOLOGY
- Structural plasticity of dendritic spines
- (2011) Miquel Bosch et al. CURRENT OPINION IN NEUROBIOLOGY
- The role of serotonin receptors in the action of atypical antipsychotic drugs
- (2011) HY Meltzer et al. CURRENT OPINION IN PHARMACOLOGY
- European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment
- (2011) Veit Roessner et al. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- 5-HT1A and 5-HT7 receptors differently modulate AMPA receptor-mediated hippocampal synaptic transmission
- (2011) L. Costa et al. HIPPOCAMPUS
- Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder
- (2011) Benny Bang-Andersen et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Role of 5-Hydroxytryptamine 7 Receptors in the Phencyclidine-Induced Novel Object Recognition Deficit in Rats
- (2011) M. Horiguchi et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Role of the 5-HT7 Receptor in the Central Nervous System: from Current Status to Future Perspectives
- (2011) Anne Matthys et al. MOLECULAR NEUROBIOLOGY
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
- (2011) Anita E. Autry et al. NATURE
- Dopamine D2 and serotonin 5-HT1A receptors mediate the actions of aripiprazole in mesocortical and mesoaccumbens transmission
- (2011) Shunsuke Tanahashi et al. NEUROPHARMACOLOGY
- Pharmacological Blockade of 5-HT7 Receptors as a Putative Fast Acting Antidepressant Strategy
- (2011) Ouissame Mnie-Filali et al. NEUROPSYCHOPHARMACOLOGY
- Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder
- (2011) Steven G. Potkin et al. SCHIZOPHRENIA RESEARCH
- Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone
- (2011) Philip D. Harvey et al. SCHIZOPHRENIA RESEARCH
- Sensory Pathways and Emotional Context for Action in Primate Prefrontal Cortex
- (2010) Helen Barbas et al. BIOLOGICAL PSYCHIATRY
- Glioblastoma chemotherapy adjunct via potent serotonin receptor-7 inhibition using currently marketed high-affinity antipsychotic medicines
- (2010) RE Kast BRITISH JOURNAL OF PHARMACOLOGY
- Effect of novel atypical antipsychotic, blonanserin, on extracellular neurotransmitter level in rat prefrontal cortex
- (2010) Keiko Ohoyama et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Different actions for acute and chronic administration of mirtazapine on serotonergic transmission associated with raphe nuclei and their innervation cortical regions
- (2010) Satoshi Yamamura et al. NEUROPHARMACOLOGY
- The 5-HT7 receptor is involved in allocentric spatial memory information processing
- (2009) Gor Sarkisyan et al. BEHAVIOURAL BRAIN RESEARCH
- Effects of zotepine on extracellular levels of monoamine, GABA and glutamate in rat prefrontal cortex
- (2009) S Yamamura et al. BRITISH JOURNAL OF PHARMACOLOGY
- Methylphenidate to adolescent rats drives enduring changes of accumbal Htr7 expression: implications for impulsive behavior and neuronal morphology
- (2009) D. Leo et al. GENES BRAIN AND BEHAVIOR
- Cytotoxic effects of antipsychotic drugs implicate cholesterol homeostasis as a novel chemotherapeutic target
- (2009) Erik D. Wiklund et al. INTERNATIONAL JOURNAL OF CANCER
- Effect of sertindole on extracellular dopamine, acetylcholine, and glutamate in the medial prefrontal cortex of conscious rats: a comparison with risperidone and exploration of mechanisms involved
- (2009) Arne Mørk et al. PSYCHOPHARMACOLOGY
- Effects of quetiapine on monoamine, GABA, and glutamate release in rat prefrontal cortex
- (2009) Satoshi Yamamura et al. PSYCHOPHARMACOLOGY
- 5-HT7 receptor stimulation by 8-OH-DPAT counteracts the impairing effect of 5-HT1A receptor stimulation on contextual learning in mice
- (2008) Therese M. Eriksson et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Inhibition of Serotonin But Not Norepinephrine Transport during Development Produces Delayed, Persistent Perturbations of Emotional Behaviors in Mice
- (2008) M. S. Ansorge et al. JOURNAL OF NEUROSCIENCE
- Rapid Synaptic Scaling Induced by Changes in Postsynaptic Firing
- (2008) Keiji Ibata et al. NEURON
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation